Drug Trial Radar · NCT03515044
Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)
Last checked: Nov 20, 2026Latest source record: Apr 13, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
71
Actual
Start
Sep 13, 2018
Primary completion
Mar 12, 2020
Study completion Mar 12, 2020
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 3, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE).
Conditions
- Overt Hepatic Encephalopathy
Interventions
40 mg Rifaximin SSD once dailyDrug
SSD once daily (QD)
40 mg Rifaximin SSD twice dailyDrug
SSD twice daily (BID)
80 mg Rifaximin SSD once dailyDrug
SSD once daily (QD)
80 mg Rifaximin SSD twice dailyDrug
SSD twice daily (BID)
PlaceboDrug
Administered twice daily (BID)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Overt Hepatic Encephalopathy (OHE) Resolution Determined Using the Hepatic Encephalopathy Grading Instrument (HEGI), Defined as HEGI Score < 2Time frame: 14 days
Locations
34 sites in 1 country. Site status is shown where the registry gives one.
Bausch Health Site 18
Corona del Mar, California
Bausch Health Site 15
Los Angeles, California
Bausch Health Site 19
Los Angeles, California
Bausch Health Site 04
San Francisco, California
Bausch Health Site 13
Bristol, Connecticut
Bausch Health Site 08
Miami, Florida
Bausch Health Site 05
Chicago, Illinois
Bausch Health Site 33
Iowa City, Iowa
Bausch Health Site 03
Boston, Massachusetts
Bausch Health Site 07
Detroit, Michigan
Bausch Health 01
Detroit, Michigan
Bausch Health Site 25
Tupelo, Mississippi
Bausch Health Site 24
St Louis, Missouri
Bausch Health Site 27
Newark, New Jersey
Bausch Health Site 36
Brooklyn, New York
Bausch Health Site 09
New York, New York
Bausch Health Site 28
New York, New York
Bausch Health Site 17
Cincinnati, Ohio
Bausch Health Site 23
Columbus, Ohio
Bausch Health Site 11
Philadelphia, Pennsylvania
Bausch Health Site 26
Philadelphia, Pennsylvania
Bausch Health Site 10
Philadelphia, Pennsylvania
Bausch Health Site 12
Pittsburgh, Pennsylvania
Bausch Health Site 16
Charleston, South Carolina
Bausch Health Site 22
Dallas, Texas
Bausch Health Site 35
Dallas, Texas
Bausch Health Site 31
Dallas, Texas
Bausch Health Site 02
Houston, Texas
Bausch Health Site 37
Houston, Texas
Bausch Health Site 30
Richmond, Virginia
Bausch Health Site 06
Richmond, Virginia
Bausch Health Site 21
Seattle, Washington
Bausch Health Site 14
Seattle, Washington
Bausch Health Site 20
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.